U.S. flag

An official website of the United States government

NM_000102.4(CYP17A1):c.1246C>T (p.Arg416Cys) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 2, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003557533.2

Allele description [Variation Report for NM_000102.4(CYP17A1):c.1246C>T (p.Arg416Cys)]

NM_000102.4(CYP17A1):c.1246C>T (p.Arg416Cys)

Gene:
CYP17A1:cytochrome P450 family 17 subfamily A member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q24.32
Genomic location:
Preferred name:
NM_000102.4(CYP17A1):c.1246C>T (p.Arg416Cys)
HGVS:
  • NC_000010.11:g.102830983G>A
  • NG_007955.1:g.11551C>T
  • NM_000102.4:c.1246C>TMANE SELECT
  • NP_000093.1:p.Arg416Cys
  • NC_000010.10:g.104590740G>A
Protein change:
R416C
Molecular consequence:
  • NM_000102.4:c.1246C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004295704Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 2, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene.

Yang J, Cui B, Sun S, Shi T, Zheng S, Bi Y, Liu J, Zhao Y, Chen J, Ning G, Li X.

J Clin Endocrinol Metab. 2006 Sep;91(9):3619-25. Epub 2006 Jun 13.

PubMed [citation]
PMID:
16772352

A rare cause of delayed puberty and primary amenorrhea: 17α-hydroxylase enzyme deficiency.

Beştaş A, Bolu S, Unal E, Aktar Karakaya A, Eröz R, Tekin M, Haspolat YK.

Endocrine. 2022 Mar;75(3):927-933. doi: 10.1007/s12020-021-02914-8. Epub 2021 Nov 1.

PubMed [citation]
PMID:
34724156
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004295704.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant is also known as R415C. This missense change has been observed in individual(s) with CYP17A1-related conditions (PMID: 11422109, 16772352, 34724156). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 416 of the CYP17A1 protein (p.Arg416Cys). Experimental studies have shown that this missense change affects CYP17A1 function (PMID: 11422109). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg416 amino acid residue in CYP17A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16849412, 17192295, 28870780). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024